Clinical Trial Update: Study to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFRO [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating LD02GIFRO for recovery of GI motility after colon/large intestinal surgery, assessing safety and determining the optimal dose; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Ileus

Drugs mentioned

• LD02GIFRO

Snippet

Sponsor: LG Life Sciences | Conditions: Colon Resection, _large Interstinal Surgery | Phase 2 | Status: COMPLETED